Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The objectives of this research is to: - Assess perceptions, concerns, and practices related to the COVID-19 pandemic and mitigation strategies using the MURDOCK Study Community Registry and Biorepository population as a measure of these features in Cabarrus County through a biweekly electronic survey. - Estimate the prevalence and change in prevalence of COVID-19 infection based on responses to questionnaire items on symptoms and practices using a biweekly electronic survey. - Among respondents to the baseline questionnaire, conduct at home mid-turbinate nasal swab collection for viral PCR testing for active COVID-19 infection as an estimate of the prevalence of active infection in Cabarrus County. - Among respondents to the baseline questionnaire, conduct serologic testing for IgG antibodies to SARS-CoV-2 as an estimate of the prevalence of exposure and potential immunity to COVID-19.
Description: RedCap link will be sent to participants electronically and they will complete and submit the questionnaire.
Measure: Estimate the prevalence of COVID-19 infection based on responses to questionnaire items on symptoms and practices using a biweekly electronic survey. Time: 6 monthsDescription: This will be accomplished using the MURDOCK Study Community Registry and Biorepository (Pro00011196) population as a measure of these features in Cabarrus County through a biweekly electronic survey
Measure: Assess perceptions, concerns, and practices related to the COVID-19 pandemic and mitigation strategies Time: 6 monthsDescription: Among respondents to the baseline questionnaire, conduct bi-weekly at home anterior nares swab collection for viral PCR testing for active COVID-19 infection
Measure: Estimate of the prevalence of active infection in Cabarrus County. Time: 6 monthsDescription: Among respondents to the baseline questionnaire, conduct bimonthly serologic testing for IgG antibodies to SARS-CoV-2
Measure: Estimate of the prevalence of exposure and potential immunity to COVID-19. Time: 6 months